Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 5
Submit an article Journal homepage
70
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

The impact of mild-to-moderate chronic kidney disease on hospitalization outcomes in patients with acute myeloid leukemia

Mohammad Ammad Ud Dina Hematology/Oncology, H. Lee Moffitt Cancer and Research Institute, Tampa, Florida;b Hematology/Oncology, University of South Florida, Tampa, FloridaORCID Iconhttps://orcid.org/0000-0001-9083-636XView further author information
ORCID Icon,
Hassan Saeedc Internal Medicine, Rochester General Hospital, Rochester, New YorkView further author information
,
Moazzam Shahzada Hematology/Oncology, H. Lee Moffitt Cancer and Research Institute, Tampa, Florida;b Hematology/Oncology, University of South Florida, Tampa, FloridaView further author information
,
Hania Liaqatc Internal Medicine, Rochester General Hospital, Rochester, New YorkView further author information
&
Kendra Sweetd Department of Hematological Malignancies, H. Lee Moffitt Cancer and Research Institute, Tampa, FloridaCorrespondence[email protected]
View further author information
Pages 1040-1044 | Received 26 Dec 2022, Accepted 06 Mar 2023, Published online: 20 Mar 2023

References

  • Pulko N, Petreski T, Hauptman J, et al. The impact of kidney function on survival in elderly patients diagnosed with acute myeloid leukemia. Clin Nephrol. 2021;96(1):31–35.
  • Murphy D, McCulloch CE, Lin F, et al. Trends in prevalence of chronic kidney disease in the United States. Ann Intern Med. 2016;165(7):473–481.
  • Fleischmann M, Schnetzke U, Hochhaus A, et al. Management of acute myeloid leukemia: current treatment options and future perspectives. Cancers. 2021;13(22):5722.
  • Overview of the National (Nationwide) Inpatient Sample (NIS).[Internet]. Agency for Healthcare Research and Quality. Available from: https://www.hcup‐us.ahrq.gov/nisoverview.jsp#about.
  • Khera R, Angraal S, Couch T, et al. Adherence to methodological standards in research using the national inpatient sample. JAMA. 2017;318(20):2011–2018.
  • Benoit DD, Hoste EA, Depuydt PO, et al. Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies. Nephrol Dial Transplant. 2005;20(3):552–558.
  • Lanore JJ, Brunet F, Pochard F, et al. Hemodialysis for acute renal failure in patients with hematologic malignancies. Crit Care Med. 1991;19(3):346–351.
  • Canet E, Zafrani L, Lambert J, et al. Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies: impact on remission and survival. PLOS One. 2013;8(2):e55870.
  • Luciano RL, Brewster UC. Kidney involvement in leukemia and lymphoma. Adv Chronic Kidney Dis. 2014;21(1):27–35.
  • Sanchez-Correa B, Bergua JM, Campos C, et al. Cytokine profiles in acute myeloid leukemia patients at diagnosis: survival is inversely correlated with IL-6 and directly correlated with IL-10 levels. Cytokine. 2013;61(3):885–891.
  • Assuncao BMBL, Handschumacher MD, Brunner AM, et al. Acute leukemia is associated with cardiac alterations before chemotherapy. J Am Soc Echocardiogr. 2017;30(11):1111–1118.
  • Mato AR, Riccio BE, Qin L, et al. A predictive model for the detection of tumor lysis syndrome during AML induction therapy. Leuk Lymphoma. 2006;47(5):877–883.
  • Darmon M, Guichard I, Vincent F, et al. Prognostic significance of acute renal injury in acute tumor lysis syndrome. Leuk Lymphoma. 2010;51(2):221–227.
  • Montesinos P, Lorenzo I, Martin G, et al. Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model. Haematologica. 2008;93(1):67–74.
  • Diao S, Nichols ED, DiNardo C, et al. Incidence of tumor lysis syndrome in patients with acute myeloid leukemia undergoing low-intensity induction with venetoclax. Am J Hematol. 2021;96(3):E65–E8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.